More costly R&D for firms rather than instant profit
The completion of the first draft of the human genome marks a scientific milestone but will not lead to any overnight breakthroughs in gene-based medicines. The mapping of the 97 per cent of the
The completion of the first draft of the human genome marks a scientific milestone but will not lead to any overnight breakthroughs in gene-based medicines. The mapping of the 97 per cent of the